https://orcid.org/0000-0002-0336-4745
Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Walaa Ebrahim Abd El Hady, Ghada Ahmed El-Emam, Nora E Saleh, Marwa M Hamouda & Amira Motawea. (2023) The Idiosyncratic Efficacy of Spironolactone-Loaded PLGA Nanoparticles Against Murine Intestinal Schistosomiasis. International Journal of Nanomedicine 18, pages 987-1005.
Read now
Read now
Articles from other publishers (4)
Antonio Lopalco, Annachiara Manni, Alexander Keeley, Shozeb Haider, Wenliang Li, Angela Lopedota, Cosimo Damiano Altomare, Nunzio Denora & Catherine Tuleu. (2022) In Vivo Investigation of (2-Hydroxypropyl)-β-cyclodextrin-Based Formulation of Spironolactone in Aqueous Solution for Paediatric Use. Pharmaceutics 14:4, pages 780.
Crossref
Crossref
R.E. Kast, T.C. Burns & M.-E. Halatsch. (2021) Short review of SEC, a potential dexamethasone-sparing regimen for glioblastoma: Spironolactone, ecallantide, clotrimazole. Neurochirurgie 67:5, pages 508-515.
Crossref
Crossref
Oscar Alejandro Bonilla-Sepúlveda. (2020) Ginecomastia: aspectos generales y etiológicos. Medicina y Laboratorio 25:1, pages 393-408.
Crossref
Crossref
Zhe Zhang, Li Zhou, Na Xie, Edouard C. Nice, Tao Zhang, Yongping Cui & Canhua Huang. (2020) Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduction and Targeted Therapy 5:1.
Crossref
Crossref